|
Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis (Greenhalgh) |
Greenhalgh J, Bagust A, Boland A, Martin Saborido C, Oyee J, Blundell M, Dundar Y, Dickson R, Proudlove C, Fisher M |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Greenhalgh J, Bagust A, Boland A, Martin Saborido C, Oyee J, Blundell M, Dundar Y, Dickson R, Proudlove C, Fisher M. Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis (Greenhalgh) Health Technology Assessment 2011; 15(31): 1-178 Indexing Status Subject indexing assigned by NLM MeSH Arterial Occlusive Diseases /complications /prevention & Aspirin /administration & Brain Ischemia /etiology /prevention & Cost-Benefit Analysis; Delayed-Action Preparations; Dipyridamole /administration & Drug Therapy, Combination; Humans; Models, Economic; Myocardial Infarction /etiology /prevention & Peripheral Arterial Disease /prevention & Platelet Aggregation Inhibitors /administration & Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Ticlopidine /administration & control; control; control; control; derivatives /economics /therapeutic use; dosage /analogs & dosage /economics /therapeutic use; dosage /economics /therapeutic use; dosage /economics /therapeutic use AccessionNumber 22011001793 Date bibliographic record published 23/01/2012 |
|
|
|